The isothermal nucleic acid amplification technology market is projected to reach USD 6.8 billion by 2028 from USD 4.4 billion in 2023, at a CAGR of 9.2% during the forecast period. Growth in the isothermal nucleic acid amplification technology market can be attributed to factors such as recent launches of INAAT consumables by prominent market players and the high prevalence of infectious diseases.
The global isothermal nucleic acid amplification technology market is highly competitive. The prominent players operating in this market are Grifols, S.A. (Spain), Hologic, Inc. (US), Abbott Laboratories (US), Becton, Dickinson and Company (US), Meridian Bioscience (US), Eiken Chemical Co., Ltd. (Japan), bioMérieux SA (France), Tecan Trading AG (Switzerland), New England Biolabs (US), QIAGEN N.V. (Germany), DiaSorin S.p.A. (Italy), General Electric (US), OptiGene Limited (UK), Quidel Corporation (US), Thermo Fisher Scientific (US), Genomtec (Poland), Mast Group Ltd. (UK), Ustar Biotechnologies (China), Jena Bioscience GmbH (Germany), Atila BioSystems (US), TwistDx Limited (UK), LGC Limited (UK), Life Sciences Advanced Technologies (US), GenoSensor Corporation (US), and PCR Biosystems (UK).
To know about the assumptions considered for the study download the pdf brochure
Hologic accounted for the largest share in the INAAT market in 2022. The company offers INAAT assays that run on the Panther Fusion platform. It will continue to have a strong market position owing to its leading platforms and assays portfolio. The firm also has a significant geographical presence and has gained a large number of FDA and CE approvals, which have fortified its presence in the global INAAT market.
Abbott Laboratories is mainly focused on launching differentiated products to strengthen its position in the isothermal nucleic acid amplification technology market. The company has a strong distribution network in North America, Europe, and Asia. This allows Abbott to introduce advanced products in the market, such as the ID NOW COVID-19 system (September 2020).
Grifols is also a leading player in this market, primarily due to its strong portfolio of INAAT assays and systems for blood screening applications. In addition, the company has strengthened its market position through the expansion of its product portfolio and recent launches such as the Procleix Plasmodium Assay (June 2022) and Procleix Panther System (May 2020).
Isothermal Nucleic Acid Amplification Technology Market by Product (Assay, System), Technology (LAMP, SDA, NASBA, NEAR, HDA), Application (Diagnostics (Influenza, Hepatitis, CT/NG, COVID-19), blood screening), End User - Global Forecast to 2028
Mr. Aashish Mehra
630 Dundee Road
Northbrook, IL 60062
USA : 1-888-600-6441
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.SEND ME A FREE SAMPLE